Michael Andreeff
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research
- Mesenchymal stem cell research
Papers in
- Hematology 527
- Acute Myeloid Leukemia Research 431
- Chronic Myeloid Leukemia Treatments 123
- Multiple Myeloma Research and Treatments 66
- Genetics 199
- Chronic Lymphocytic Leukemia Research 115
- Co-authors
- Marina Y Konopleva (251 shared papers)Hagop Kantarjian (221 shared papers)Frank C. Marini (34 shared papers)Steven Mitchell Kornblau (134 shared papers)Jörge E. Cortes (132 shared papers)Erika L. Spaeth (15 shared papers)Ismael J. Samudio (40 shared papers)Ann H. Klopp (11 shared papers)
- Journals
- Blood (351 papers)Leukemia (42 papers)Cancer (26 papers)Cancer Research (26 papers)Haematologica (21 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Michael Andreeff
1.0k papers receiving 61.0k citations
Michael Andreeff's Hit Papers
Peers
Comparison fields: 5 of 173
- Hematology 21.0k
- Genetics 11.7k
- Cancer Research 8.4k
- Oncology 15.3k
- Molecular Biology 30.7k
Countries citing papers authored by Michael Andreeff
This map shows the geographic impact of Michael Andreeff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Andreeff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Andreeff more than expected).
Fields of papers citing papers by Michael Andreeff
This network shows the impact of papers produced by Michael Andreeff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Andreeff. The network helps show where Michael Andreeff may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Andreeff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.0k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid) Hit paper breakdown → | 1991 | 1137 |
| 2 | Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas Hit paper breakdown → | 2005 | 917 |
| 3 | Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia Hit paper breakdown → | 2006 | 899 |
| 4 | Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Hit paper breakdown → | 2002 | 805 |
| 5 | Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia Hit paper breakdown → | 2005 | 781 |
| 6 | Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression Hit paper breakdown → | 2009 | 692 |
| 7 | Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia Hit paper breakdown → | 2000 | 677 |
| 8 | 2009 | 673 | |
| 9 | 2009 | 614 | |
| 10 | Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia Hit paper breakdown → | 2013 | 608 |
| 11 | Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging Hit paper breakdown → | 2009 | 602 |
| 12 | Cancer stem cell definitions and terminology: the devil is in the details Hit paper breakdown → | 2012 | 576 |
| 13 | 2006 | 565 | |
| 14 | Convention on nomenclature for DNA cytometry Hit paper breakdown → | 1984 | 561 |
| 15 | Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. | 2000 | 540 |
| 16 | 2008 | 521 | |
| 17 | 2008 | 495 | |
| 18 | 2001 | 493 | |
| 19 | 2010 | 478 | |
| 20 | 2001 | 476 |
About Michael Andreeff
Michael Andreeff is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Cancer Research, having authored 1.0k papers that have together received 62.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (431 papers), Chronic Myeloid Leukemia Treatments (123 papers), Chronic Lymphocytic Leukemia Research (115 papers), Acute Lymphoblastic Leukemia research (115 papers), Cell death mechanisms and regulation (103 papers), Retinoids in leukemia and cellular processes (74 papers), Protein Degradation and Inhibitors (66 papers) and Multiple Myeloma Research and Treatments (66 papers). The work is most often cited by research in Hematology (21.0k citations), Genetics (11.7k citations), Cancer Research (8.4k citations), Oncology (15.3k citations) and Molecular Biology (30.7k citations). Michael Andreeff has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Marina Y Konopleva, Hagop Kantarjian, Frank C. Marini, Steven Mitchell Kornblau, Jörge E. Cortes, Erika L. Spaeth, Ismael J. Samudio, Ann H. Klopp, Teresa J. McQueen and Jennifer Lynn Dembinski. Their work appears in journals such as Blood, Leukemia, Cancer, Cancer Research and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.